Login to Your Account



SangStat's Ulcerative Colitis Drug Positive In Phase II, Fails Crohn's

By Randall Osborne


Thursday, April 10, 2003
With a new CEO installed and a recent favorable court ruling, SangStat Medical Corp. chalked up more good news Wednesday: positive preliminary Phase II data with RDP58, its drug for ulcerative colitis. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription